Utilization of human recombinant Tinagl1 protein in inhibiting triple-negative-breast cancer progression and metastasis Princeton Docket # 19-3526Researchers in Princeton University’s Department of Molecular Biology have developed the human recombinant protein Tubulointerstitial nephritis antigen like-1 (Tinagl1) as a promising treatment for triple-negative...
Published: 9/27/2024
|
Inventor(s): Yibin Kang, Minhong Shen
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|